USPTO serial 90604160
HARNESSING THE REGENERATIVE POWER OF INFLAMMATION
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- May 3, 2022
- Examiner
- ELTON, DAVID JONATHAN
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with HARNESSING THE REGENERATIVE POWER OF INFLAMMATION?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Gwenn Roos
Gwenn Roos ONSIDECOUNSEL/LAW OFFICE OF GWENN ROOS26 BROOKDALE AVENUEWELLESLEY, MA 02482UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 042 | Medical research; Medical research in the field of infectious diseases; Medical research services in the field of cancer; Medical and scientific research in the field of cancer treatment and diagnosis; Medical and scientific research in the field of inflammation, immunology, regeneration, pain management and reduction, and other neuro- degenerative diseases; Medical and scientific research information in the field of inflammation, immunology, regeneration, pain management and reduction, and other neuro- degenerative diseases; Research and development in the pharmaceutical and biotechnology fields; Research and development of vaccines; Research and development of vaccines and medicines; Research and development in the field of medicine and pharmaceuticals; Research in the field of inflammation, immunology, regeneration, pain management and reduction, and other neuro- degenerative diseases; Scientific research; Scientific research and development; Scientific research consulting in the field of cosmetics; Scientific research for medical purposes in the field of inflammation, immunology, regeneration, pain management and reduction, and other neuro- degenerative diseases; Scientific consulting and research services relating to foods and dietary supplements; Biochemical research and development; Cell culture services for scientific and research purposes, for others; Genetic testing for scientific research purposes; Pharmaceutical research and development; Providing information on the subject of scientific research in the field of biochemistry and biotechnology; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Scientific research for medical purposes in the area of cancerous diseases | ACTIVE | Feb 10, 2022 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by CarthroniX, Inc.
- Other trademarks owned by CarthroniX, Inc.
- Other trademarks owned by CarthroniX, Inc.
- Other trademarks in Class 042
- Similar marks named HARNESSING THE REGENERATIVE POWER OF INFLAMMATION
- Prosecution event R.PR explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| May 3, 2022 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Mar 29, 2022 | SUNA | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | — |
| Mar 26, 2022 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| Mar 24, 2022 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| Mar 24, 2022 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Feb 26, 2022 | IUAF | USE AMENDMENT FILED | — |
| Feb 26, 2022 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| Feb 1, 2022 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Dec 7, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Dec 7, 2021 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Nov 17, 2021 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Nov 2, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Nov 2, 2021 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Nov 2, 2021 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Nov 2, 2021 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Nov 2, 2021 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Nov 1, 2021 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 1, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Mar 29, 2021 | NWAP | NEW APPLICATION ENTERED | — |